These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Impulsive conditions in Parkinson's disease: A pharmacosurveillance-supported list. Fusaroli M; Raschi E; Contin M; Sambati L; Menchetti M; Fioritti A; Poluzzi E Parkinsonism Relat Disord; 2021 Sep; 90():79-83. PubMed ID: 34399162 [TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors. Seeman P Synapse; 2015 Apr; 69(4):183-9. PubMed ID: 25645960 [TBL] [Abstract][Full Text] [Related]
7. Impulse control disorders in Chinese Parkinson's disease patients: the effect of ergot derived dopamine agonist. Auyeung M; Tsoi TH; Tang WK; Cheung CM; Lee CN; Li R; Yeung E Parkinsonism Relat Disord; 2011 Sep; 17(8):635-7. PubMed ID: 21705258 [TBL] [Abstract][Full Text] [Related]
8. Impulse control symptoms in patients with Parkinson's disease: The influence of dopaminergic agonist. Vargas AP; Vaz LS; Reuter A; Couto CM; Costa Cardoso FE Parkinsonism Relat Disord; 2019 Nov; 68():17-21. PubMed ID: 31621612 [TBL] [Abstract][Full Text] [Related]
9. Impulsive smoking in a patient with Parkinson's disease treated with dopamine agonists. Bienfait KL; Menza M; Mark MH; Dobkin RD J Clin Neurosci; 2010 Apr; 17(4):539-40. PubMed ID: 20171891 [TBL] [Abstract][Full Text] [Related]
10. A Man With Persistent Dopamine Agonist Withdrawal Syndrome After 7 Years Being Off Dopamine Agonists. Huynh NT; Sid-Otmane L; Panisset M; Huot P Can J Neurol Sci; 2016 Nov; 43(6):859-860. PubMed ID: 26842385 [No Abstract] [Full Text] [Related]
11. Impulse Control Disorders in Parkinson's Disease: An Overview of Risk Factors, Pathogenesis and Pharmacological Management. Carbone F; Djamshidian A CNS Drugs; 2024 Jun; 38(6):443-457. PubMed ID: 38613665 [TBL] [Abstract][Full Text] [Related]
14. [Hypersexuality and other impulse control disorders in Parkinson's disease]. Nelis EA; Berendse HW; van den Heuvel OA Ned Tijdschr Geneeskd; 2016; 160():A9359. PubMed ID: 26732226 [TBL] [Abstract][Full Text] [Related]
15. Drug-induced impulse control disorders: a review. Atmaca M Curr Clin Pharmacol; 2014 Feb; 9(1):70-4. PubMed ID: 24219002 [TBL] [Abstract][Full Text] [Related]
16. Resolution of dopamine dysregulation syndrome following cessation of dopamine agonist therapy in Parkinson's disease. Kimber TE; Thompson PD; Kiley MA J Clin Neurosci; 2008 Feb; 15(2):205-8. PubMed ID: 18068992 [TBL] [Abstract][Full Text] [Related]
17. Management of impulse control disorders in Parkinson's disease: Controversies and future approaches. Samuel M; Rodriguez-Oroz M; Antonini A; Brotchie JM; Ray Chaudhuri K; Brown RG; Galpern WR; Nirenberg MJ; Okun MS; Lang AE Mov Disord; 2015 Feb; 30(2):150-9. PubMed ID: 25607799 [TBL] [Abstract][Full Text] [Related]
19. Impulse control disorders in Parkinson's disease. Marques A; Durif F; Fernagut PO J Neural Transm (Vienna); 2018 Aug; 125(8):1299-1312. PubMed ID: 29511827 [TBL] [Abstract][Full Text] [Related]
20. The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study. Vela L; Martínez Castrillo JC; García Ruiz P; Gasca-Salas C; Macías Macías Y; Pérez Fernández E; Ybot I; Lopez Valdés E; Kurtis MM; Posada Rodriguez IJ; Mata M; Ruiz Huete C; Eimil M; Borrue C; Del Val J; López-Manzanares L; Rojo Sebastian A; Marasescu R J Neurol Sci; 2016 Sep; 368():150-4. PubMed ID: 27538621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]